Valneva has entered into a settlement agreement with the UK Government in relation to the termination of the supply agreement for its Covid-19 vaccine candidate, VLA2001.
On 13 September, it received a termination notice from the government, after having begun the production process at its facility outside Livingston.
Some 100 million doses of the vaccine were put on order after the UK increased its request by 40 million last February.
